NovAliX is a drug discovery focused CRO with award-winning chemistry teams and one of the world’s most comprehensive biophysics platforms. Bruker and NovAliX intend to collaborate on enabling new paradigms in drug discovery, leveraging advanced biophysical methods, and NMR in particular, to structural, binding and functional characterization. STRASBOURG, France–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today... Read more
Q2 2024 revenues of $800.7 million, up 17.4% year-over-year (yoy); organic revenue up 7.4% yoy; CER revenue up 18.5% yoy Q2 2024 GAAP EPS $0.05; non-GAAP EPS $0.52, up 4.0% yoy Bruker increases FY 2024 revenue guidance to $3.38-$3.44 billion, now including the NanoString business; implies revenue growth of 14% to 16%, and organic revenue... Read more
Bruker Announces Date and Time of Second Quarter 2024 Earnings Release and Webcast BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2024 financial results before market opening on Tuesday, August 6, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the... Read more
Revenue of $2.2 billion , up 26% on a reported basis and 9% organically Earnings per share of $0.80 , up 78%; $1.09 on an adjusted basis, up 11% Raising full-year revenue guidance to $8.55 billion , up approximately 16%, with organic revenue growth of 5% to 6%, up from 4% to 6% Increasing full-year Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29, 2024. Second Quarter 2024 Highlights Second quarter revenue was $10.54 billion. Second quarter GAAP diluted earnings per share (EPS) increased 15% to $4.04. Second quarter adjusted EPS increased... Read more
WASHINGTON, July 23, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended June 28, 2024. All results in this release reflect only continuing operations unless otherwise noted. Key Second Quarter 2024 Results Net earnings were $907 million, or $1.22 per diluted common share and non-GAAP adjusted diluted net... Read more
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, August 7, 2024, at 4:30 pm Eastern Time. The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/. Date:... Read more
ANDOVER, Mass., July 15, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release second quarter 2024 financial results after market close on Wednesday, August 7, 2024. Read more
Xylem’s Venture Investing Strategy Targets Direct Investments in Innovative Startups and Leading Venture Capital Partners WASHINGTON –(BUSINESS WIRE)–Jul. 10, 2024– Global water technology leader Xylem (NYSE: XYL) is expanding its corporate venture investing plans with $50 million committed to Read more
WASHINGTON –(BUSINESS WIRE)–Jun. 25, 2024– Xylem Inc. (NYSE: XYL), a leading global water technology company that empowers customers and communities to build a more water-secure world, will release its second quarter 2024 results at 6:55 a.m. (ET) on Tuesday, July 30, 2024 . At 9:00 a.m. Read more